News | Health & Safety
21 Nov 2017 19:01
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     21 Nov: Concern for life of Rohingya refugee injured in motorbike accident on Nauru
     21 Nov: F&P Healthcare 1H profit up 4 per cent
     19 Nov: Tanzil was paid just $6 a day to work in a fireworks factory which became an inferno
     18 Nov: Three respond to botulism anti-toxin
     18 Nov: Staggering fall in youth, Maori smokers
     17 Nov: Man suffering from scleroderma dies
     17 Nov: Graduate to research Pacific plants
     Top Stories

    RUGBY RUGBY
    All Blacks as dangerous as ever: Gatland More...


    BUSINESS BUSINESS
    'Outdated' Lincoln's blueprint for change More...



     Today's News

    International:
    WWI diggers' relatives celebrate decision not to build wind farm near French battlefield 18:57

    Entertainment:
    David Cassidy is reportedly out of his coma, but remains in intensive care 18:50

    Rugby League:
    Jillaroos still yet to peak: Sims 18:37

    Rugby League:
    England go under radar for RLWC semi 18:37

    Entertainment:
    Morrissey has claimed Kevin Spacey has been "needlessly attacked" over an allegation of sexual misconduct 18:20

    Business:
    'Outdated' Lincoln's blueprint for change 18:07

    International:
    Srebrenica massacre survivor hits back at genocide deniers ahead of war crimes verdict 17:57

    Entertainment:
    Nick Jonas hopes he'll be asked to be the best man at his brother Joe Jonas' wedding 17:50

    Motoring:
    Kabul to Calais: A 13-year-old's dangerous attempt to reach a new life in London 17:27

    Rugby League:
    Detained Kikau re-unites with Fiji squad 17:27


     News Search






    Power Search


    © 2017 New Zealand City Ltd